Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT06761833
Starting soon Observational

Postoperative Behavioral Changes in Children.

NCT06761833 · tracked via the Priya Life Science Turkey tracker
Sponsor
Baskent University
Phase
Observational
Started
2025-01
Last updated
2025-01-07

Condition(s) studied

Behavior ProblemsPediatricsPediatric Pain and Anxiety

Study summary

In children scheduled for dental treatment, negative thoughts can lead to anxiety and make them resistant to treatment techniques. In our prospective, single-center observational study, we aim to investigate preoperative anxiety and postoperative negative behaviors in children aged 3 to 12 years who are set to undergo general anesthesia for dental conditions and treatments.

Eligibility

Sex
ALL
Min age
3 Years
Max age
12 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Patients categorized as American Society of Anesthesiologists (ASA) groups 1 and 2. 2. Children aged 3 to 12 years who are scheduled to receive dental treatment under general anesthesia. Exclusion Criteria: 1. The child patient or parent has a diagnosed psychiatric disorder. 2. There is a history of substance use that may affect cognitive function. 3. The parent has declined to participate in the study. 4. The child patient or parent does not speak Turkish. 5. Patients categorized as American Society of Anesthesiologists (ASA) group 3 and 4.

Primary outcome measure(s)

  • The effect of preoperative anxiety level on postoperative behavioral changes in children receiving dental treatment under general anesthesia. — one year
    This observational study, conducted at a single center, aims to investigate the occurrence of negative postoperative behavior in children

Trial sites (1)

FacilityCityRegionStatus
Baskent Universty Adana Hospital Adana Turkey (Türkiye)

More Baskent University trials in Turkey

Periodization-Based Strength Exercise Training in İndividuals With Type 2 Diabetes Recruiting
The Effect of Post-Scenario Debriefing and Rapid Cycle Deliberate Practice in Anaphylactic Shock Training on Nursing Students' Knowledge, Performance, Self-Confidence, and Satisfaction Active, not recruiting
The Effect of Music and Musical Mobile Interventions on Pain and Physiological Parameters Recruiting
Effectiveness of High Intensity Laser Therapy in Management of Lumbar Disc Herniation Starting soon
AI-SUPPORTED FLIPPED LEARNING IN BREAST SELF-EXAMINATION TRAINING Recruiting

Other trials for the same condition

Turkish Version of the BRIEF-Hammersmith Infant Neurological Examination (HINE) Recruiting
Hemoglobin Levels and Resolution Time of Diabetic Ketoacidosis in Pediatric Patients Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06761833 on ClinicalTrials.gov ↗ ← All trials in Turkey